What does the prescribing information say about breastfeeding during binimetinib treatment?

For Mektovi (binimetinib), milk excretion of binimetinib or its metabolite is unknown and risk to breastfed newborns/infants cannot be excluded; a decision must be made to stop breastfeeding or Mektovi, considering breastfeeding benefits for the child and treatment benefits for the mother.